Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma

被引:0
|
作者
Friedrich, RE
Bartel-Friedrich, S
Lobeck, H
Niedobitek, G
Arps, H
机构
[1] Univ Hamburg, Eppendorf Univ Hosp, Nordwestdeutsch Kieferklin, Klin MKG Chirurg,Dept Oral & Maxillofacial Surg, D-20246 Hamburg, Germany
[2] Univ Halle Wittenberg, Halle, Germany
[3] Free Univ Berlin, Charite, Dept Pathol, D-1000 Berlin, Germany
[4] Free Univ Berlin, Benjamin Franklin Hosp, Dept Pathol, D-1000 Berlin, Germany
[5] Gen Hosp, Dept Pathol, Fulda, Germany
关键词
undifferentiated carcinoma; nasopharyngeal carcinoma; intermediate filaments; Epstein-Barr virus; cytokeratins;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate the expression of intermediate filaments (cytokeratin, vimentin), epithelial membrane antigen (EMA) and the presence of Epstein-Barr virus (EBV) DNA in undifferentiated nasophalyngeal carcinoma (NPC). A high incidence of nuclear signals in NPC was Sound in primaries and regional lymph node metastases (70%), using S-35-labelled probes of EBV plasmids for in-situ hybridization. Keratinizing squamous cell carcinomas were EBV-negative. All carcinomas were immune-reactive for cytokeratin (KL-1). 45% of the carcinomas were positive for vimentin. The expression of epithelial membrane antigen was restricted to epithelial cells and reduced in NPC as compared to the distribution pattern of cytokeratin. Both EBV DNA and vimentin in NPC were present in 9 cases. However, in 5 cases NPG were harboring EBV but were not immunoreactive for anti-vimentin antibodies. In no case was a vimentin-positive NPC also EBV-negative. The identification of cytokeratin subtypes revealed no specific cytokeratin pattern in NPC. The expression of vimentin in NPC is not specific for EBV, but seems to reflect the loss of intel-epithelial contact in anaplastic carcinomas.
引用
收藏
页码:4909 / 4916
页数:8
相关论文
共 50 条
  • [31] Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma
    Tsai, ST
    Jin, YT
    Mann, RB
    Ambinder, RF
    CANCER, 1998, 82 (08) : 1449 - 1453
  • [32] Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma
    Prayongrat, Anussara
    Chakkabat, Chakkapong
    Kannarunimit, Danita
    Hansasuta, Pokrath
    Lertbutsayanukul, Chawalit
    JOURNAL OF RADIATION RESEARCH, 2017, 58 (04) : 509 - 516
  • [33] Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
    Yoshizaki, Tomokazu
    Kondo, Satoru
    Endo, Kazuhira
    Nakanishi, Yosuke
    Aga, Mitsuharu
    Kobayashi, Eiji
    Hirai, Nobuyuki
    Sugimoto, Hisashi
    Hatano, Miyako
    Ueno, Takayoshi
    Ishikawa, Kazuya
    Wakisaka, Naohiro
    CANCER SCIENCE, 2018, 109 (02): : 272 - 278
  • [34] Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1
    Yoshizaki, T
    HISTOLOGY AND HISTOPATHOLOGY, 2002, 17 (03) : 845 - 850
  • [35] Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
    Farrell, PJ
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (01): : 14 - 15
  • [36] Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
    Tan, Rong
    Phua, Sean Kean Ann
    Soong, Yoke Lim
    Oon, Lynette Lin Ean
    Chan, Kian Sing
    Lucky, Sasidharan Swarnalatha
    Mong, Jamie
    Tan, Min Han
    Lim, Chwee Ming
    CANCER COMMUNICATIONS, 2020, 40 (11) : 564 - 585
  • [37] Prognostic Value of Oral Epstein-Barr Virus DNA Load in Locoregionally Advanced Nasopharyngeal Carcinoma
    He, Yong-Qiao
    Zhou, Ting
    Yang, Da-Wei
    Jia, Yi-Jing
    Yuan, Lei-Lei
    Zhang, Wen-Li
    Wang, Tong-Min
    Liao, Ying
    Xue, Wen-Qiong
    Zhang, Jiang-Bo
    Zheng, Xiao-Hui
    Li, Xi-Zhao
    Zhang, Pei-Fen
    Zhang, Shao-Dan
    Hu, Ye-Zhu
    Wang, Fang
    Cho, William C.
    Ma, Jun
    Sun, Ying
    Jia, Wei-Hua
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [38] Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma
    Hsiao, JR
    Jin, YT
    Tsai, ST
    CANCER, 2002, 94 (03) : 723 - 729
  • [39] Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma
    Yosuke Nakanishi
    Naohiro Wakisaka
    Satoru Kondo
    Kazuhira Endo
    Hisashi Sugimoto
    Miyako Hatano
    Takayoshi Ueno
    Kazuya Ishikawa
    Tomokazu Yoshizaki
    Cancer and Metastasis Reviews, 2017, 36 : 435 - 447
  • [40] Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma
    Ogino, Takeshi
    Moriai, Shigetaka
    Ishida, Yoshiya
    Ishii, Hideyuki
    Katayama, Akihiro
    Miyokawa, Naoyuki
    Harabuchi, Yasuaki
    Ferrone, Soldano
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (11) : 2401 - 2410